Last reviewed · How we verify

NCT04258384

The Turkish Cross-Cultural Adaptation, Validity and Reliability of VMPCI

Completed Last updated 6 February 2020
What this trial tests

trial testing survey application in Pain, Chronic in 352 participants. Completed in 31 December 2019.

Timeline
1 June 2019
Primary endpoint
30 December 2019
31 December 2019

Quick facts

Lead sponsorYeditepe University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment352
Start date1 June 2019
Primary completion30 December 2019
Estimated completion31 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Yeditepe University

Who can join

18 and older, any sex, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned to adapt the Vanderbilt Multidimensional Pain Coping Inventory into Turkish, to investigate its cultural adaptation, validity and reliability. The study was completed with 352 volunteers who fulfilled the criteria to be included in the Rheumatology Clinic of Istanbul Haydarpaşa Numune Training and Research Hospital. Data collection tools used in the study; Demographic Data Form, Mcgill and Melzack Pain Questionnaire, Short Form-36 (SF-36), Vanderbilt Multidimensional Pain Coping Inventory (VMPCI), Pain Coping Inventory (PCI), Pain Coping Scale were used.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of survey application

Trials testing the same drug.

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

Other Yeditepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04258384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing